ClinicalTrials.gg
RecruitingNCT05777291ICareUpdated Feb 23, 2024

IntelligentCare: Wearable-based Intervention

An interventional study of Activity watch monitoring and Sleep mattress monitoring in Multimorbidity, Exercise and Sleep, sponsored by GLSMED Learning Health S.A.. Recruiting at 1 site in Portugal. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2024-02-23.

Sponsored by GLSMED Learning Health S.A. · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Dec 2024, 1 year 11 months ago, but the record still lists the study as recruiting.
  • Started Apr 2023; still recruiting 3 years 7 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Randomized
Ages
65 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 104 studies in Motor Activity with a site in Portugal — 35 open to participants now, 43 under way, none of them phase 3. Motor Activity · Portugal.

Planned enrollment
43rd of 100
80 · median 69
Started
2023
with 8 others
No phase
97 of 104
34 open now
Primary completion
2024-12
later than 6 of 42 live
Registered
48th of 104
by date

Among the 104 studies in Motor Activity with a site in Portugal, this one is the 43rd largest by planned enrollment of the 100 interventional ones that give a count, is one of 9 that started in 2023, is one of 97 with no phase, reaches primary completion later than 6 of the 42 other live ones, and was the 48th registered.

Motor Activity

9,827 studies on the registry are indexed under Motor Activity; 1,911 are open to participants now.

Browse Motor Activity studies →

Open to participants now

35 of the 104 studies in Motor Activity with a site in Portugal are open now. Recruiting first, the newest first:

29 more — sign in →

All 35 open studies →

A study can be open while its sites in Portugal have not opened yet or have stopped. Only those recruiting at a site in Portugal →

Who these studies take

Of the 1,207 Motor Activity studies recruiting now, 524 (43%) set no upper age limit and 538 (45%) stop at 75 or younger; 180 take children under 18; 420 take healthy volunteers.

This study: 65 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 104 studies in Motor Activity with a site in Portugal, or all of them as a file.
02

Study summary

The benefits of physical activity and adequate sleep are well documented, and their importance strengthens with the increasing prevalence of chronic diseases and multimorbidity. Interventions to promote physical activity and sleep that use commercial activity trackers may be useful non-pharmacological approaches to managing individual health; however, limited evidence exists on their use to improve physical activity in elderly patients with multimorbidity. This study aims to measure the effects of behavioral change techniques (BCTs) delivered by a wearable device on physical activity (PA) and quality of sleep (QS) in elderly patients with multimorbidity. The investigators designed an open-label randomized controlled trial with participants recruited through primary care and a specialist outpatient clinic. Participants must be more than 65 years old, have multimorbidity, and have access to smartphones. All eligible participants will receive PA promotion content and will be randomly assigned to wear a smartwatch. The primary outcome will be the participants' PA measurement at six months using the IPAQ-SF. Secondary outcomes will include changes in the participants' frailty status, biometric measurements, quality of life, and biopsychosocial assessments. A sample size of 40 participants per arm was calculated to detect group differences, with 50 participants recruited and randomized into each arm. This study aims to contribute to a better understanding of PA patterns and the impact of smartwatch-based PA interventions in patients with multimorbidity. The trial's findings are expected to improve our understanding of how physical activity patterns, patient-reported outcomes (PROMs), and healthcare resource utilization are linked in patients with multiple medical conditions. The study will use a registry for locally developed PROMs and data from the participants' medical records to determine how wearable data and medical information data can be used to predict PROMs and unplanned hospital admissions.

03

Conditions studied

  • Multimorbidity
  • Exercise
  • Sleep

Browse trials for

04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Multimorbidity defined as the presence of two or more of the following chronic conditions: hypertension, depression or anxiety, chronic musculoskeletal conditions causing pain or limitation, arthritis and/or rheumatoid arthritis, osteoporosis, asthma, , ischemic heart disease, peripheral artery disease, heart failure, cerebrovascular diseases, chronic stomach or colon conditions, chronic hepatitis, diabetes mellitus, thyroid disorders, any active cancer in the previous five years, chronic kidney disease, chronic urinary conditions, hyperlipidemia, and obesity
  • Must have access to their smartphones

Exclusion criteria

Exclusion Criteria:

  • patients who are sufficiently physically active (IPAQ-SF > 150 min aerobic physical activity per week)
  • existing absolute for PA according to the American College of Sports Medicine (acute myocardial infarction within two days, ongoing unstable angina, uncontrolled cardiac arrhythmia with hemodynamic compromise, active endocarditis, symptomatic severe aortic stenosis, decompensated heart failure, acute pulmonary embolism, pulmonary infarction, deep venous thrombosis, acute myocarditis or pericarditis, acute aortic dissection, physical disability that precludes safe and adequate testing)
  • poor comprehension of Portuguese language
  • disabling neurological disorder (defined as mRankin score ≥4), severe psychiatric illness, learning disability, dementia and cognitive impairment, registered blind
  • housebound or resident in a nursing home or non-ambulant
  • advanced cancer
  • scheduled for surgery within five months after the first consultation
  • orthopedic or rheumatologic diseases with severe impairment
  • chronic pain syndromes with inherently reduced mobility
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

COPD

Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
80 participants (estimated)

Study arms

  • Experimental
    Experimental arm

    Patients will be given physical activity recommendations ABD will be using the study devices: activity watch (Fitbit Sense) and a sleep monitoring mattress (Withings, Sleep Analyzer)

    Device: Activity watch monitoring · Device: Sleep mattress monitoring · Behavioral: Physical activity counseling

  • Active comparator
    Control arm

    Patients will be given physical activity recommendations only

    Behavioral: Physical activity counseling

Interventions

  • DeviceActivity watch monitoring

    Patients will be using activity devices during the study period

  • DeviceSleep mattress monitoring

    Patients will be using sleep mattress during the study period

  • BehavioralPhysical activity counseling

    Physical activity counseling in accordance to the Swedish model

06

What researchers measure

Primary outcomes

  1. Physical activity

    Physical activity measured trough International Physical Activity Questionnaire Short Form. The responses to these questions are used to calculate an individual's total physical activity level, expressed in metabolic equivalent of task (MET) minutes per week. The IPAQ-Sf assigns a MET value to each activity reported by the individual and multiplies this value by the reported duration of the activity to calculate the total MET-minutes per week for each domain. The total MET-minutes per week for all domains are then summed to give the total physical activity level for the individual. The results of the IPAQ-Sf can be used to classify individuals into different categories of physical activity levels, such as low, moderate, or high.

    Time frame: 6 months after study entry

Secondary outcomes

  1. Physical performance

    Assessed trough Short Physical Performance Battery. It is a non-invasive test designed to assess physical performance in older adults, with three parts. Each component of the SPPB test is scored on a scale of 0 to 4 points, with a maximum total score of 12 points. A higher score indicates better physical performance and mobility.

    Time frame: 6 months after study entry

  2. Fall risk

    Assessed trough a validated 4-question questionnaire where any positive question indicates fall risk. More positive answers indicate greater risk.

    Time frame: 6 months after study entry

  3. Weight

    Weight measured in Kgs and reported in isolation and with Body Mass Index

    Time frame: 6 months after study entry

  4. Abdominal circunference

    Abdominal circunference in cm

    Time frame: 6 months after study entry

  5. Calf circunference

    Calf circunference in cm

    Time frame: 6 months after study entry

  6. Health-related quality of life

    Short Form Survey 12 that generates two summary scores, the physical component summary (PCS) score and the mental component summary (MCS) score. The PCS score reflects an individual's physical health status and the MCS score reflects their mental health status. Scores are standardized, with a mean of 50 and a standard deviation of 10, so scores above 50 indicate better health status than the reference population and scores below 50 indicate worse health status.

    Time frame: 6 months after study entry

  7. Biopsychosocial complexity and health care needs

    INTERMED self-assessment questionnaire consists of 23 items that assess different aspects of a patient's health and social situation, such as the presence of chronic pain, mental health problems, social support, and functional impairment. Results are used to calculate an overall INTERMED score, which ranges from 0 to 60. The higher the score, the greater the complexity of the patient's health and social situation.

    Time frame: 6 months after study entry

  8. Unplanned hospital admissions

    Number of emergency department visits and unplanned hospital admissions during study period

    Time frame: 6 months after study entry

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Apr 2023 (actual). Primary completion is estimated for Dec 2024, 20 months after the start.

Of 5,176 non-industry interventional studies with no phase under Motor Activity, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 36. This study's planned 20 months is above that.

Counting every sponsor, half of 5,236 studies reached it within 17 months; a quarter within 7 and three quarters within 36.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 3, 2023
First posted
Mar 21, 2023
StartActual
Apr 1, 2023
Primary completionEst.
Dec 2024
CompletionEst.
Mar 2025
Last update
Feb 23, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 23, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05777291
Lead sponsor
GLSMED Learning Health S.A.
Responsible party
Sponsor
First posted
Mar 21, 2023
Start date
Apr 1, 2023
Primary completion
Dec 2024 (estimated)
Completion
Mar 2025 (estimated)
Last update
Feb 23, 2024

Study contacts

Bernardo Neves, MD
Contact
bernardo.neves@hospitaldaluz.pt
00351217104544
Nuno Silva, PhD
Contact
nuno.asilva@luzsaude.pt
Bernardo Neves, MD
principal investigator · Researcher

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion